Over the past decades, large-scale human genetic studies have identified numerous risk genes and variants associated with complex diseases and traits.
10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback